Automatic vs. As-Needed Follow-Up for Infections
(FAAN-C Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best follow-up methods for children discharged from the hospital after common infections, such as pneumonia or urinary tract infections. It compares two approaches: one where parents decide if a follow-up is needed based on their child's symptoms (as-needed follow-up) and another where a follow-up is automatically scheduled (automatic follow-up). The goal is to determine which method aids better recovery. Children hospitalized for these infections, whose parents speak English or Spanish, may be suitable participants, provided they do not have other complex health issues. As an unphased trial, this study offers a unique opportunity to improve post-hospital care for children.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these follow-up methods are safe for children?
Research has shown that families can safely decide if their child needs a follow-up visit after hospitalization for common infections. Studies found that this approach does not increase the likelihood of the child returning to the hospital. Allowing families to choose when to have a follow-up visit proves effective and does not lead to more complications compared to automatically scheduling these visits. Overall, evidence supports that this flexible follow-up can safely care for children after they leave the hospital.12345
Why are researchers excited about this trial?
Researchers are excited about the trial exploring follow-up methods for infections because it aims to optimize post-hospital care. Unlike the traditional approach where everyone schedules a follow-up regardless of symptoms, this trial investigates whether as-needed follow-ups can be just as effective. This could empower patients to make informed decisions about their own care, potentially reducing unnecessary medical visits and resource use. The trial's focus on patient-driven follow-up represents a shift towards more personalized healthcare, which could improve patient satisfaction and outcomes.
What evidence suggests that this trial's follow-up methods could be effective for infections?
This trial will compare two follow-up strategies after hospitalization for infections: as-needed follow-up and automatic follow-up. Research has shown that allowing parents to decide when to follow up after their child is hospitalized for common infections can be effective and safe. Specifically, studies found that this approach results in 62% fewer follow-up visits while still easing parents' worries as effectively as automatic follow-ups. It enables families to monitor their child's symptoms and decide if a visit is necessary, offering more convenience and less stress. Conversely, automatic follow-up involves a scheduled check-up regardless of symptom changes, which some parents might find reassuring. Both methods have their advantages, with as-needed follow-up showing promise in reducing unnecessary visits.13467
Who Is on the Research Team?
Eric Coon, MD
Principal Investigator
University of Utah
Are You a Good Fit for This Trial?
Children under 18 hospitalized for pneumonia, skin infections, gastroenteritis, or urinary tract infection can join. They must speak English or Spanish. Kids with chronic diseases, needing surgery beyond minor procedures, with immune issues, or scheduled follow-ups within a week of discharge cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either automatic or as-needed (PRN) post-hospitalization follow-up recommendations
Follow-up
Participants are monitored for hospital readmissions and other outcomes after discharge
What Are the Treatments Tested in This Trial?
Interventions
- As-needed follow up
- Automatic follow-up
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator